PROPE Severe Asthma Study in Egypt

Study identifier:D3250R00122

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

Prevalence of the OCS Use Among Severe Asthma Patients in Egypt: A Nation-wide, Cross-Sectional, Multicenter Study

Medical condition

Severe Asthma

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

150

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 01 Mar 2024
Estimated Primary Completion Date: 31 Jul 2024
Estimated Study Completion Date: 31 Jul 2024

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria